Prognostic value of serial C-reactive protein measurements in left-sided native valve endocarditis

Archives of Internal Medicine

Volumn 168, Issue 3, 2008, Pages 302-307

  Verhagen, Dominique W M ^a,b   Hermanides, Jeroen ^a   Korevaar, Joke C ^a   Bossuyt, Patrick M M ^a   Van Den Brink, Renee B A ^a   Speelman, Peter ^a   Van Der Meer, Jan T M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Jan Van Goyen Clinic   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; C REACTIVE PROTEIN;

ABSCESS; ADULT; AGE; AGED; ARTICLE; BACTERIAL INFECTION; CONFIDENCE INTERVAL; DEATH; ENDOCARDITIS; FEMALE; FOLLOW UP; HEART SURGERY; HEART VALVE; HUMAN; INFECTIOUS COMPLICATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; STAPHYLOCOCCUS AUREUS; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; ENDOCARDITIS, BACTERIAL; FEMALE; HEART VALVE DISEASES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 39549085131     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2007.73     Document Type: Article

References (25)

1. Romano G, Carozza A, Della Corte A, et al. Native versus primary prosthetic valve endocarditis: comparison of clinical features and long-term outcome in 353 patients. J Heart Valve Dis. 2004;13(2):200-208.
2. Hecht SR, Berger M. Right-sided endocarditis in intravenous drug users: prognostic features in 102 episodes. Ann Intern Med. 1992;117(7):560-566.
3. Hasbun R, Vikram HR, Barakat LA, Buenconsejo J, Quagliarello VJ. Complicated left-sided native valve endocarditis in adults: risk classification for mortality. JAMA. 2003;289(15):1933-1940.
4. Di Salvo G, Thuny F, Rosenberg V, et al. Endocarditis in the elderly: clinical, echocardiographic, and prognostic features. Eur Heart J. 2003;24(17):1576-1583.
5. Cabell CH, Pond KK, Peterson GE, et al. The risk of stroke and death in patients with aortic and mitral valve endocarditis. Am Heart J. 2001;142(1):75-80.
6. Durante Mangoni E, Adinolfi LE, Tripodi MF, et al. Risk factors for "major" embolic events in hospitalized patients with infective endocarditis. Am Heart J. 2003;146(2):311-316.
7. van der Meer JT, Thompson J, Valkenburg HA, Michel MF. Epidemiology of bacterial endocarditis in the Netherlands, I: patient characteristics. Arch Intern Med. 1992;152(9):1863-1868.
8. Vigushin DM, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human CRP in health and disease. J Clin Invest. 1993;91(4):1351-1357.
9. Olaison L, Hogevik H, Alestig K. Fever, CRP and other acute-phase reactants during treatment of infective endocarditis. Arch Intern Med. 1997;157(8):885-892.
10. Heiro M, Helenius H, Sundell J, et al. Utility of serum CRP in assessing the outcome of infective endocarditis. Eur Heart J. 2005;26(18):1873- 1881.
11. Durack DT, Lukes AS, Bright DK; Duke Endocarditis Service. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med. 1994;96(3):200-209.
12. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005;111(23):e394-e434.
13. Hoen B, Alla F, Selton-Suty C, et al; Association pour l'Etude et la Prévention de l'Endocardite Infectieuse (AEPEI) Study Group. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA. 2002;288(1):75-81.
14. Nunley DL, Perlman PE. Endocarditis: changing trends in epidemiology, clinical and microbiologic spectrum. Postgrad Med. 1993;93(5):235-238, 241-244, 247.
15. Hogevik H, Olaison L, Andersson R, Lindberg J, Alestig K. Epidemiologic aspects of infective endocarditis in an urban population: a 5-year prospective study. Medicine (Baltimore). 1995;74(6):324-339.
16. Hellgren U, Julander I. Are white blood cell count, platelet count, erythrocyte sedimentation rate and CRP useful in the diagnosis of septicaemia and endocarditis? Scand J Infect Dis. 1986;18(5):487-488.
17. Hogevik H, Olaison L, Andersson R, Alestig K. C-reactive protein is more sensitive than erythrocyte sedimentation rate for diagnosis of infective endocarditis. Infection. 1997;25(2):82-85.
18. Lindbäck S, Hellgren U, Julander I, Hansson LO. The value of C-reactive protein as a marker of bacterial infection in patients with septicaemia/endocarditis and influenza. Scand J Infect Dis. 1989;21(5):543-549.
19. Mueller C, Huber P, Laifer G, Mueller B, Perruchoud AP. Procalcitonin and the early diagnosis of infective endocarditis. Circulation. 2004;109(14):1707-1710.
20. Koegelenberg CF, Doubell AF, Orth H, Reuter H. Infective endocarditis: improving the diagnostic yield. Cardiovasc J S Afr. 2004;15(1):14-20.
21. Alter P, Hoeschen J, Ritter M, Maisch B. Usefulness of cytokines interleukin-6 and interleukin-2R concentrations in diagnosing active infective endocarditis involving native valves. Am J Cardiol. 2002;89(12):1400- 1404.
22. Lamas CC, Eykyn SJ. Suggested modifications to the Duke criteria for the clinical diagnosis of native valve and prosthetic valve endocarditis: analysis of 118 pathologically proven cases. Clin Infect Dis. 1997;25(3):713-719.
23. McCartney AC, Orange GV, Pringle SD, Wills G, Reece IJ. Serum C reactive protein in infective endocarditis. J Clin Pathol. 1988;41(1):44-48.
24. Kocazeybek B, Küçükoǧlu S, Oner YA. Procalcitonin and C-reactive protein in infective endocarditis: correlation with etiology and prognosis. Chemotherapy. 2003;49(1-2):76-84.
25. Blaustein AS, Lee JR. Indications for and timing of surgical intervention in infective endocarditis. Cardiol Clin. 1996;14(3):393-404.